Repeal Safe Harbor to Medicare AntiKickback Statute.
Duration: September 1, 2009
to
January 31, 2011
General Issues: Health Issues , Consumer Issues/Safety/Protection , Manufacturing , Medical/Disease Research/Clinical Labs , Medicare/Medicaid , Science/Technology , Small Business , Trade (Domestic & Foreign)
Spending: about $31,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS), Justice - Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Federal Trade Commission (FTC), White House Office, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2011
Cindy Fithian & Associates LLC terminated an engagement in which they represented Adroit Medical Systems on Feb. 3, 2012.
Original Filing: 300455123.xml
Lobbying Issues
Repeal Safe Harbor to Medicare AntiKickback Statute.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2010
In Q4, Ms. Cindy Fithian lobbied for Adroit Medical Systems , earning $10,000. The report was filed on Feb. 1, 2011.
Original Filing: 300356905.xml
Lobbying Issues
Working to repeal the GPO Safe Harbor Exemption from the Medicare Anti-kickback Statute.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Justice - Dept of (DOJ) Medicare Payment Advisory Commission (MedPAC) Federal Trade Commission (FTC) White House Office
3rd Quarter, 2010
In Q3, Cindy Fithian & Associates LLC (formerly Cindy Fithian & Associates) lobbied for Adroit Medical Systems , earning $10,000. The report was filed on Oct. 20, 2010.
Original Filing: 300329898.xml
Lobbying Issues
Repeal Safe Harbor for GPOs from the Medicare antikickback statute. Regulate and enforce transparent competition in hospital and nursing home purchasing.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Federal Trade Commission (FTC) Health & Human Services - Dept of (HHS) Justice - Dept of (DOJ)
2nd Quarter, 2010
In Q2, Cindy Fithian & Associates LLC (formerly Cindy Fithian & Associates) lobbied for Adroit Medical Systems , earning $6,000. The report was filed on July 20, 2010.
Original Filing: 300297639.xml
Lobbying Issues
HR3962 Affordable Health Care for America Act and S1679 Affordable Health Choices Act - Repeal of the "Safe Harbor" in the Medicare anti-kickback statute, Social Security Act, 1986; mandate and enforce tranparent, competitive bidding in the medical device sector of hosiptal and nursing home purchasing; and to expose the corrupt business model of the dominant corporations and the Groups Purchasing Organizations (GPOs)the effort to get an investigation opened on Gaymar Industries - Adroits competitor and marketshare leader, who continues to distribute thermoregulation products that were altered post-FDA approval
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Justice - Dept of (DOJ) Federal Trade Commission (FTC) White House Office
Type of Issue
Consumer Issues/Safety/Protection
1st Quarter, 2010
Cindy Fithian & Associates LLC terminated an engagement in which they represented Adroit Medical Systems on May 12, 2011.
Original Filing: 300383702.xml
Lobbying Issues
Repeal of Safe Harbor, exemption to the Medicare anti-kickback statute.
1st Quarter, 2010
In Q1, Cindy Fithian & Associates LLC (formerly Cindy Fithian & Associates) lobbied for Adroit Medical Systems , earning $5,000. The report was filed on April 19, 2010.
Original Filing: 300265666.xml
Lobbying Issues
HR3962 Affordable Health Care for America Act and S1679 Affordable Health Choices Act - Repeal of the Safe Harbor in the Medicare anti-kickback statute, Social Security Act, 1986; mandate and enforce transparent, competitive bidding in the medical device sector of hospital and nursing home purchasing; and to expose the corrupt business model of the dominant corporations and the Group Purchasing Organizations (GPOs)the effort to get an investigation opened on Gaymar Industries Adroits competitor and marketshare leader, who continues to distribute thermoregulation products that were altered post-FDA approval.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Justice - Dept of (DOJ) Federal Trade Commission (FTC) White House Office
Type of Issue
Consumer Issues/Safety/Protection
4th Quarter, 2009
In Q4, Cindy Fithian & Associates LLC (formerly Cindy Fithian & Associates) lobbied for Adroit Medical Systems . The report was filed on Jan. 19, 2010.
Original Filing: 300237617.xml
Lobbying Issues
HR3962 Affordable Health Care for America Act and S1679 Affordable Health Choices Act - Repeal of the Safe Harbor in the Medicare anti-kickback statute, Social Security Act, 1986; mandate and enforce transparent, competitive bidding in the medical device sector of hospital and nursing home purchasing; and to expose the corrupt business model of the dominant corporations and the Group Purchasing Organizations (GPOs)the effort to get an investigation opened on Gaymar Industries Adroits competitor and marketshare leader, who continues to distribute thermoregulation products that were altered post-FDA approval.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Justice - Dept of (DOJ) Federal Trade Commission (FTC) White House Office
Type of Issue
Consumer Issues/Safety/Protection
3rd Quarter, 2009
Cindy Fithian & Associates LLC (formerly Cindy Fithian & Associates) filed a lobbying registration on Dec. 16, 2009 to represent Adroit Medical Systems, effective Sept. 1, 2009.
Original Filing: 300226535.xml
Issue(s) they said they’d lobby about: small business issues related to medical device inventors/manufacturers/medical supply delivery stakeholders as they relate toward transparent competition in the medical marketplace of hospital and nursing home purchasing .
3rd Quarter, 2009
In Q3, Cindy Fithian & Associates LLC (formerly Cindy Fithian & Associates) lobbied for Adroit Medical Systems . The report was filed on Dec. 17, 2009.
Original Filing: 300226562.xml
Lobbying Issues
HR3962 Affordable Health Care for America Act and S1679 Affordable Health Choices Act - Repeal of the Safe Harbor in the Medicare anti-kickback statute, Social Security Act, 1986; mandate and enforce transparent, competitive bidding in the medical device sector of hospital and nursing home purchasing; and to expose the corrupt business model of the dominant corporations and the Group Purchasing Organizations (GPOs)the effort to get an investigation opened on Gaymar Industries Adroits competitor and marketshare leader, who continues to distribute thermoregulation products that were altered post-FDA approval.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Food & Drug Administration (FDA) Health & Human Services - Dept of (HHS) Justice - Dept of (DOJ) Federal Trade Commission (FTC) White House Office
Type of Issue
Consumer Issues/Safety/Protection
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate